NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE158795 Query DataSets for GSE158795
Status Public on May 27, 2021
Title Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells [RNA-seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Blood production is maintained through adult life by haematopoietic stem cells which undergo a process of differentiation and increasing lineage restriction to produce all the terminal blood types. The cell type transitions within this process are tightly controlled, and loss of control can lead to inappropriate proliferation and leukemic transformation. We and others have previously described seven transcriptional regulators (heptad; LYL1, TAL1, LMO2, FLI1, ERG, GATA2, RUNX1) which bind key haematopoietic genes in normal human CD34+ haematopoietic stem and progenitor cells (HSPCs). Heptad factors form a densely interconnected circuit by binding combinatorically at their own, and each other’s, regulatory elements. However, the precise role of the heptad throughout normal and leukemic haematopoiesis, including whether all seven factors act together in single cells, and whether heptad perturbation can influence cell fate decisions remain unclear. In this study we integrate bulk and single cell data in normal human HSPCs and leukemic cells and find that chromatin conformation at key heptad regulatory elements is predictive of cell identity in normal and leukemic progenitors. The interconnected heptad circuit identified in normal HSPCs persists in AML, but single cell transcriptomics suggest that specific heptad sub-circuits exist in individual cells, and we show that GATA2, TAL1 and ERG play key roles in regulating the stem to erythroid transition in both normal and leukemic contexts.
 
Overall design RNAseq of primary human CD34+ HSPCs lentivirally transduced with shRNAs targetting luciferse (control) or ERG.
 
Contributor(s) Thoms J, Pimanda J, Zanini F, Seneviratne J
Citation(s) 34075404
Submission date Sep 30, 2020
Last update date Aug 27, 2021
Contact name Julie Thoms
E-mail(s) j.thoms@unsw.edu.au
Organization name UNSW Sydney
Department Adult Cancer Program
Street address Level 2, C25 Lowy Cancer Research Centre, UNSW Sydney, High St
City Randwick
State/province NSW
ZIP/Postal code 2052
Country Australia
 
Platforms (1)
GPL20301 Illumina HiSeq 4000 (Homo sapiens)
Samples (4)
GSM4810558 CD34 shLUC control Rep 1
GSM4810559 CD34 shERG Rep 1
GSM4810560 CD34 shLUC control Rep 2
This SubSeries is part of SuperSeries:
GSE158797 Disruption of a GATA2, TAL1, ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells
Relations
BioProject PRJNA666569
SRA SRP285884

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE158795_summary_AS_CD34kd_deSeq_analysis.txt.gz 1.0 Mb (ftp)(http) TXT
GSE158795_summary_AS_CD34kd_deSeq_normalized_sample_labels.txt.gz 402.5 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap